Myelofibrosis cells in blood flow

Clinical trial data for MF candidate proves promising for Syntara

Syntara Ltd has reported positive interim results from its Phase 2 trial to test the efficacy…
Laboratory with bottles and test tubes

Sonic to acquire ‘Top 5’ laboratory group in Germany

Sonic Healthcare Ltd has signed agreements for the acquisition of LADR laboratory group, which has a…
3D image of the lungs

4D Medical inks deal with WA radiology clinics for ventilation report tech

Melbourne-based 4D Medical Ltd has signed a commercial contract with Perth Radiological Clinic to roll out…
Medical imaging of the human heart

Monash tests show strong cardioprotective qualities for Algorae drug candidate

Algorae Pharmaceutical Ltd has completed preclinical tests on its drug candidate for heart disease, AI-168
Image of a doctor using imaging software

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

Pro Medicus Ltd is set to roll out a suite of diagnostic imaging products across the…
Doctor investigating an image of a uterus

Cleo adds Royal Women’s Hospital to its clinical trial for ovarian cancer diagnosis

Cleo Diagnostics Ltd has expanded its clinical trial for a blood test to detect ovarian cancer,…
Man holding health IT icon

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision…
AI image of molecular structure

Race identifies 39 new molecules with potential to inhibit cancer-associated protein

Race Oncology Ltd has completed a successful drug discovery program started in 2022 at Monash University…
Image of stacked coins and an arrow moving upwards

Visionflex set to bank $1.75M to fund inventory expansion

Visionflex Group Ltd has carried out an institutional Placement bringing in $1.75M, beyond its original target…
3D model of prostate cancer cells

Clarity progresses SECuRE trial with positive safety results

Clarity Pharmaceuticals Ltd has reported strong results from Cohort 4 of the SECuRE trial examining a…